Early intervention is critical in managing patients with immune-related adverse events associated with cancer checkpoint inhibitor therapy, according to a presenter at the 2020 Interdisciplinary Autoimmune Summit.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.